|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Amortization of debt-related costs | |||||
| Severance Costs | |||||
| Right-of-use assets | |||||
| Loss on disposal of property and equipment | |||||
| Accretion of marketable securities purchased at a discount | |||||
| Other non-cash adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease (increase) in accounts receivable | |||||
| (Increase) decrease in inventories | |||||
| Decrease (increase) in prepaid expenses and other current assets | |||||
| Decrease in other long-term assets | |||||
| (Decrease) increase in accounts payable and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock, net of fees | |||||
| Proceeds from issuance of common stock for equity incentive plans | |||||
| Proceeds from issuance of preferred stock, net of fees | |||||
| Payments for tax withholding on share-based compensation vesting | |||||
| Debt payments | |||||
| Proceeds from debt borrowings, net of fees | |||||
| Other debt financing fees | |||||
| Net cash (used in) provided by financing activities | |||||
| Cash and cash equivalents at end of year | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year | |||||
| Cash, cash equivalents, and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Common stock, $.001 par value; 225,000 shares authorized; 106,679 and 106,162 shares issued, respectively | |||||
| Right-of-use assets obtained in exchange for operating lease obligations | |||||
| Issuance of equity-classified warrants | |||||
| Issuance of treasury stock | |||||
| Accrual of deferred financing costs | |||||
| Conversion of preferred stock to common stock | |||||
Loading...